|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 14
Zeitschriftenartikel
Rule, Simon; Barreto, Wolney Gois; Briones, Javier; Carella, Angelo M.; Casasnovas, Olivier; Pocock, Chris; Wendtner, Clemens-Martin; Zaja, Francesco; Robson, Susan; MacGregor, Lachlan; Tschopp, Roger R.; Nick, Sonja und Dreyling, Martin
(2022):
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase Ill MabCute study.
In: Haematologica, Bd. 107, Nr. 2: S. 500-509
[PDF, 811kB]
Noe, Sebastian; Zange, Sabine; Seilmaier, Michael; Antwerpen, Markus H.; Fenzl, Thomas; Schneider, Jochen; Spinner, Christoph D.; Bugert, Joachim J.; Wendtner, Clemens-Martin und Wölfel, Roman
(2022):
Clinical and virological features of first human monkeypox cases in Germany.
In: Infection, Bd. 51, Nr. 1: S. 265-270
Luft, Thomas; Wendtner, Clemens-Martin; Kosely, Florentina; Radujkovic, Aleksandar; Benner, Axel; Korell, Felix; Kihm, Lars; Bauer, Matthias F.; Dreger, Peter und Merle, Uta
(23. Juni 2021):
EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.
In: Frontiers in Immunology, Bd. 12, 634416
[PDF, 642kB]
Schwarz, Tatjana; Heiss, Kirsten; Mahendran, Yuvaraj; Casilag, Fiordiligie; Kurth, Florian; Sander, Leif E.; Wendtner, Clemens-Martin; Hoechstetter, Manuela A.; Müller, Marcel A.; Sekul, Renate; Drosten, Christian; Stadler, Volker und Corman, Victor M.
(23. März 2021):
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
In: Frontiers in Immunology, Bd. 12, 629185
[PDF, 2MB]
Stilgenbauer, Stephan; Morschhauser, Franck; Wendtner, Clemens-Martin; Cartron, Guillaume; Hallek, Michael; Eichhorst, Barbara; Kozloff, Mark F.; Giever, Thomas; Lozanski, Gerard; Jiang, Yanwen; Huang, Huang; Pignataro, Daniela Soriano; Schary, William; Humphrey, Kathryn; Mobasher, Mehrdad und Salles, Gilles
(2021):
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440).
In: Haematologica, Bd. 106, Nr. 11: S. 2834-2844
Ludolph, Kristina; Hauner, Dagmar; Nüssler, Volkmar; Wendtner, Clemens-Martin und Hauner, Hans
(2020):
Barrieren für Ernährungstherapie in der stationären Hämatologie/Onkologie.
In: Ernahrungs Umschau, Bd. 67, Nr. 9:
M536-M544
Wendtner, Clemens-Martin
(2019):
Ibrutinib: the home run for cure in CLL?
In: Blood, Bd. 133, Nr. 19: S. 2003-2004
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228
Alpermann, Tamara; Schnittger, Susanne; Eder, Christiane; Dicker, Frank; Meggendorfer, Manja; Kern, Wolfgang; Schmid, Christoph; Aul, Carlo; Staib, Peter; Wendtner, Clemens-Martin; Schmitz, Norbert; Haferlach, Claudia und Haferlach, Torsten
(2016):
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.
In: Haematologica, Bd. 101, Nr. 2, E55-E58
Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela und Fischer, Kirsten
(2016):
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.
In: European Journal of Haematology, Bd. 97, Nr. 3: S. 253-260
Wendtner, Clemens-Martin und Polliack, Aaron
(2016):
Basophils go wild when mosquitoes bite CLL.
In: Leukemia & Lymphoma, Bd. 57, Nr. 10: S. 2243-2244
Cheson, Bruce D.; Brugger, Wolfram; Damaj, Gandhi; Dreyling, Martin; Kahl, Brad; Kimby, Eva; Ogura, Michinori; Weidmann, Eckhart; Wendtner, Clemens-Martin und Zinzani, Pier Luigi
(2016):
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update.
In: Leukemia & Lymphoma, Bd. 57, Nr. 4: S. 766-782
Schlemmer, Marcus; Wendtner, Clemens-Martin; Falk, Martin; Abdel-Rahman, Sultan; Licht, Thomas; Baumert, Jens; Straka, Christian; Hentrich, Marcus; Salat, Christoph; Hiddemann, Wolfgang und Issels, Rolf-Dieter
(2006):
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
In: Oncology, Nr. 1-2: S. 32-39
[PDF, 150kB]
Schlemmer, M.; Wendtner, Clemens-Martin und Issels, Rolf-Dieter
(2003):
Ifosfamide with regional hyperthermia in soft-tissue sarcomas.
In: Oncology, Nr. 2: S. 76-79
[PDF, 52kB]